Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Changes in D(2) receptors during antidepressant therapy have been reported in patients with major depressive disorder using PET/SPET. The aim of this study was to evaluate modifications in D(2) receptors that might occur in patients affected by obsessive-compulsive disorder (OCD) during serotonin reuptake sites inhibitors (SSRIs). To this purpose, we measured the in vivo binding of [(11)C]raclopride ([(11)C]Rac)in the brain of a group of OCD naïve patients before and after the repeated administration of the inhibitor SSRI fluvoxamine. Eight patients with a Diagnostic and Statistical Manual of Mental Disorders IVth edition diagnosis of OCD completed the study undergoing a PET scan and a complete clinical evaluation before and during treatment with fluvoxamine. Patients have been compared also with a group of nine age-matched normal volunteers. Fluvoxamine treatment significantly improved clinical symptoms and increased [(11)C]Rac binding potential (BP) in the basal ganglia of OCD patients (7.5+/-5.2, 6.9+/-6.9, and 9.9+/-9.3% in dorsal caudate, dorsal putamen, and ventral basal ganglia, respectively; p<0.01) to values closer to those observed in the group of normal subjects. Chronic treatment with fluvoxamine induces a slight but significant increase in striatal [(11)C]Rac BP of previously drug-naïve OCD patients. The modifications in D(2) receptor availability might be secondary to fluvoxamine effects on serotoninergic activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a system apparently impaired in OCD (Denys et al. 2004; Hesse et al. 2005; Moresco et al. 2007; Olver et al. 2009, 2010; Perani et al. 2008; Sesia et al. 2013; Van Der Wee et al. 2004)”
From Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder (2019) · cites this paper as Moresco et al. 2007
In the citing paper
“Evidence from human molecular imaging studies of patients with OCD suggests a possible role for dopaminergic pathology in OCD (Denys et al. 2004; Hesse et al. 2005; Moresco et al. 2007; Olver et al. 2009, 2010; Perani et al. 2008; Sesia et al. 2013; Van Der Wee et al. 2004).”
From Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder (2019) · cites this paper as Moresco et al. 2007
Citations
Cites
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131 · cited 2×
“In particular, (a) dopamine regulates cortico-striatal-thalamo-cortical circuits through its activity on indirect and direct pathway (Alexander and Crutcher, 1990); (b) structural damages to the basal ganglia, a region particularly rich in dopamine receptors, promote OCD symptoms (Carmin et al, 2002); (c) a supersensi…”
Background3D statistical neuroanatomical models from 305 MRI volumes
Evans, A. C., Collins, D. L., Mills, S. R., Brown, E. D., Kelly, R. L., & Peters, T. M. (2005) · 1993 IEEE Conference Record Nuclear Science Symposium and Medical Imaging Conference · doi:10.1109/nssmic.1993.373602 · Cited by 1,487 · cited 1×
“Parametric images were then normalized to the Montreal Neurological Institute (MNI) stereotactic space (Evans et al, 1993) using SPM99 software (Wellcome Department of Imaging Neuroscience).”
MethodBaxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodEvidence for striatal dopamine release during a video game
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Bench, C. J., & Grasby, P. M. (1998) · Nature · doi:10.1038/30498 · Cited by 1,279 · cited 1×
“This property of [11C]Rac binding, has been used, as an innovative strategy, to measure in living human subjects the modification in extracellular/synaptic dopamine concentration induced by pharmacological or behavioral stimulations (Laruelle, 2000b; Koepp et al, 1998).”
MethodParametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,084 · cited 1×
“Radioactivity distribution images were transformed pixel by pixel into BP images and relative influx images (RI) using the RPM (reversible reference tissue model) software developed by R Gunn et al (Gunn et al, 1997).”
MethodImaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944 · cited 2×
“This property of [11C]Rac binding, has been used, as an innovative strategy, to measure in living human subjects the modification in extracellular/synaptic dopamine concentration induced by pharmacological or behavioral stimulations (Laruelle, 2000b; Koepp et al, 1998).”
BackgroundMethodMultimodal Image Coregistration and Partitioning—A Unified Framework
Ashburner, J., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 927 · cited 1×
“5 (Ashburner and Friston, 1997).”
Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder
Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297870 · Cited by 831 · cited 1×
“[11C]Rac binding has been proven to be sensitive to modification in extracellular concentration of exogenous or endogenous dopamine (Seeman et al, 1989; Laruelle, 2000a).”
BackgroundFunctional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder
Breiter, H. C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070041008 · Cited by 626 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodMawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
Cited by
Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Obsessive-compulsive disorder: Puzzles and prospects
Robbins, T. W., Vaghi, M. M., & Banca, P. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.046 · Cited by 510
Nikolaus, S., Antke, C., Beu, M., & Müller, H.-W. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.2.119 · Cited by 243
Nakao, T., Okada, K., & Kanba, S. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12195 · Cited by 231
“[72] reported that [ 11 C]-Raclopride, which is a selective D2 receptor antagonist, increased the D2 binding potential significantly in the basal ganglia of OCD patients,”
Mosconi, M. W., Kay, M., D'Cruz, A.-M., Seidenfeld, A., Guter, S., Stanford, L. D., & Sweeney, J. A. (2009) · Psychological Medicine · doi:10.1017/s0033291708004984 · Cited by 222
“…be established, but observations that inhibitory control deficits are evident in both groups and are reduced by serotonergic drugs in neuropsychiatric disorders (Rosenberg et al. 2000 ; Moresco et al. 2007) suggest that frontostriatal disruption is one commonality in these behavioral disturbances.”
Background
Metadata
- Authors
- Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., & Fazio, F.
- Affiliations
- Institute of Molecular Bioimaging and Physiology (IT)
- IRCCS Ospedale San Raffaele (IT)
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Moresco, Rosa Maria
- Venue
- Neuropsychopharmacology
- Published
- 2006-10-04
- Volume
- 32
- Issue
- 1
- Pages
- 197-205
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2048998525
- Cited by
- 70
- References
- 51
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- obsessive-compulsive disorder, fluvoxamine, dopamine D2 receptor, serotonin reuptake inhibitors, [11C]raclopride, basal ganglia, drug-naive patients
- MeSH terms
- Adult, Basal Ganglia, Brain Mapping, Carbon Isotopes, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Protein Binding, Tissue Distribution, Fluvoxamine, Selective Serotonin Reuptake Inhibitors, Receptors, Dopamine D2, Dopamine Antagonists, Raclopride, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients. https://app.cochat.ai/papers/10.1038/sj.npp.1301199
- The paper
- Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., & Fazio, F. (2007). Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1301199
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.